Projects per year
Organization profile
organization profile
Chilean biotechnology company engaged in research, development and commercialization of innovative cell therapies based on adult stem cells. Cells for Cells is a spin off of the University of the Andes, Chile, and was founded in 2010.
organization profile
Chilean biotechnology company engaged in research, development and commercialization of innovative cell therapies based on adult stem cells. Cells for Cells is a spin off of the University of the Andes, Chile, and was founded in 2010.
Fingerprint
Dive into the research topics where Cells for Cells is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Juan Pablo Acevedo, Doctorado
- Claustro Doctorado en Biomedicina
- Cells for Cells
- Centro de Investigación e Innovación Biomédica
- Doctorado en Biomedicina
- Facultad de Medicina
- Grupo de Ingeniería de Tejidos y Biofabricación
- Medicina
- Programa de Terapia Celular
- Regenero
Person: Researcher, Academic, Full graduate faculty members
-
Francisca Alcayaga-Miranda, Doctorado
- Claustro Doctorado en Biomedicina
- Cells for Cells
- Centro de Investigación e Innovación Biomédica
- Doctorado en Biomedicina
- Facultad de Medicina
- Grupo de Biología y Función de Exosomas en Cáncer
- Medicina
- Programa de Terapia Celular
- Regenero
Person: Researcher, Academic, Full graduate faculty members
-
INVESTIGATING THE EFFECT OF MAVS ENRICHED MITOCHONDRIAL TRANSPLANTATION ON INTRACELLULAR ANTIVIRAL IMMUNITY AND THEIR RESTORATIVE AND IMMUNOMODULATORY EFFECTS IN A VIRALINDUCED ACUTE LUNG INJURY MODEL
Cuenca, J., Alcayaga-Miranda, F., Khoury, M., Hidalgo, Y. & Kurte, M.
Agencia Nacional de Investigación y Desarrollo (ANID), Chile
1/04/21 → 31/03/25
Project: Research
-
A Chemically Defined, Xeno- and Blood-Free Culture Medium Sustains Increased Production of Small Extracellular Vesicles From Mesenchymal Stem Cells
Figueroa-Valdés, A. I., de la Fuente, C., Hidalgo, Y., Vega-Letter, A. M., Tapia-Limonchi, R., Khoury, M. & Alcayaga Miranda, F., 26 May 2021, In: Frontiers in Bioengineering and Biotechnology. 9, p. 619930 619930.Research output: Contribution to journal › Article › peer-review
Open Access -
Camouflage strategies for therapeutic exosomes evasion from phagocytosis
Parada, N., Romero-Trujillo, A., Georges, N. & Alcayaga Miranda, F., 1 Jul 2021, In: Journal of Advanced Research. 31, p. 61-74 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Editorial: The Role of Metabolism in MSC-Mediated Immunomodulation
Pers, Y. M., Jorgensen, C. & Khoury, M., 26 Aug 2021, In: Frontiers in Immunology. 12, p. 751865 751865.Research output: Contribution to journal › Editorial
Open Access
Prizes
-
Beca Predoctoral "Cátedra Severo Ochoa", Consejo Superior de Investigaciones Científicas-Banco Santander Central Hispano.
Cuenca, Jimena (Recipient), 1 Mar 2002
Prize: Other distinction
-
-
Beca predoctoral “CNIC-BanCaja”, Centro Nacional de Investigaciones Cardiovasculares (CNIC).
Cuenca, Jimena (Recipient), 1 Oct 2004
Prize: Other distinction
Activities
-
Stem cells translational medicine (Journal)
Jimena Cuenca (Reviewer)
2 Jan 2019 → 1 Oct 2022Activity: Publication peer-review and editorial work › Publication Peer-review
-
International Society of Cell and Gene Therapy, ISCT Annual Meeting
Jimena Cuenca (Participant)
29 May 2019 → 1 Jun 2019Activity: Participating in or organizing an event › Participating in a conference, workshop, ...
-
Evaluador/a del Programa de Atracción e Inserción de Capital Humano Avanzado (PAI) de ANID.
Francisca Alcayaga-Miranda (Examiner)
2019Activity: Examination
Courses
-
Avances en terapia celular
Patricia Alejandra Luz Crawford, Jimena Cuenca, Francisca Alcayaga-Miranda, Maroun Khoury & Juan Pablo Acevedo 13/08/21 → 17/12/21
Course
-
-
Press / Media
-
Clinical Trial: Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1)
29/09/21
2 items of Media coverage
Press/Media
-
US Patent Issued to Cells for Cells on June 22 for "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells" (Chilean Inventors)
23/06/21
1 item of Media coverage
Press/Media